Pronounced inhibition of phosphorylation of c-Met, PI3K, Akt, MEK, and ERK was witnessed in the tumor tissues derived from DA-treated mice, inferring that the observed antitumor effects are primarily due to the mitigation of c-Met and its downstream oncogenic pathways. The gene discussed is AKT1; the disease is neoplasm.